How many drugs treat Malignant tumor of testis?

Drug Landscape tracks 5 marketed treatments for Malignant tumor of testis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-tumor-of-testis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant tumor of testis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant tumor of testis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant tumor of testis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vepesid	etoposide	Bristol-Myers Squibb K.K.	Topoisomerase Inhibitor [EPC]	DNA topoisomerase 2-alpha	1983-01-01
Cosmegen	DACTINOMYCIN	Recordati	Actinomycin [EPC]	DNA	1964-01-01
Vinblastin	Vinblastin	The Lymphoma Academic Research Organisation		Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1
Etoposid	Etoposid	University of Ulm		Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2, Multidrug resistance-associated protein 6
Mithramycin	Mithramycin	National Cancer Institute (NCI)

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Malignant tumor of testis
Bristol-Myers Squibb K.K. · 1 drug in Malignant tumor of testis
National Cancer Institute (NCI) · 1 drug in Malignant tumor of testis
Recordati · 1 drug in Malignant tumor of testis
The Lymphoma Academic Research Organisation · 1 drug in Malignant tumor of testis
University of Ulm · 1 drug in Malignant tumor of testis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant tumor of testis:

Cite this brief

Drug Landscape (2026). Malignant tumor of testis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-tumor-of-testis. Accessed 2026-06-10.

Malignant tumor of testis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing